Nelipak Corp. said last week that Roger Prevot will take over as CEO, following the retirement of current CEO Michael Kelly.
Kelly was in charge when private equity giant Kohlberg bought Nelipak for an undisclosed amount July 2. Kelly is retiring after overseeing the deal and positioning the company for the next phase of its development, according to a news release.
Kohlberg partner Prevot has served as the chairman of Nelipak’s board of directors since Kohlberg acquired the company. He has also served as president & COO of Graham Packaging, CEO of Packaging Dynamics Corp., chairman of the board of Spectrum Plastics Group and chairman at Cadence.
Part of the Kohlberg acquisition that Prevot will oversee in his new role is a merger with Bemis Healthcare Packaging Europe, which was picked up by Mount Kisco, N.Y.-based Kohlberg in August. The announcement prompted the U.K.’s Competition & Markets Authority to open an anti-monopoly probe into the proposed merger on August 13.
Cranston, R.I.-based Nelipak manufactures rigid healthcare packaging used in Class II and Class III medical devices and pharma drug-delivery products. The company also has in-house design, development, prototyping, manufacturing and quality teams to assist in the production of medical trays and blisters, surgical procedure trays, pharmaceutical handling trays and more.
“I look forward to leading Nelipak into the next phase of its development as the legacy Nelipak business is integrated with the former European healthcare packaging business of Bemis Corporation,” Prevot said in prepared remarks.
“I am proud of the accomplishments we have achieved together at Nelipak and the recent sale to Kohlberg,” added Kelly. “Roger’s distinguished track record, together with his strong professional and personal values, make him an outstanding successor to lead Nelipak into the future. I wish Roger and the people of Nelipak much continued success in the years to come.”
“On behalf of the board of directors of Nelipak, I wish to sincerely thank Mike for his distinguished service to the company,” Kohlberg partner Seth Hollander said. “Mike was instrumental in building a foundation for sustained growth at Nelipak. As chairman, Roger has been instrumental in the creation of the current Nelipak and its plan for transformational initiatives going forward. As a result of his vision, Nelipak is well-positioned for continued excellence in innovation and customer service as well as growth execution.”
ElectroCore appoints Goldberger as CEO
ElectroCore (NSDQ:ECOR) named Daniel Goldberger as its CEO and appointed him as a member of the board of directors, effective Oct. 1 with a term lasting through 2022. Goldberger takes over a few weeks after Electrocore’s shares plunged when the FDA asked for more data on a bid for an expanded indication for its GammaCore device.
Nelson tabbed as CEO at Q’Apel Medical
Q’Apel Medical announced that King Nelson is joining the company as CEO. Nelson, an industry veteran, previously served as president & CEO at Uptake Medical, Kerberos Solutions and VenPro Cardiovascular.
Invo Bioscience picks Shum as CEO
Invo Bioscience (OTCQB:IVOB) selected Steven Shum as its new CEO, effective Oct. 14, following the retirement of Kathleen Karloff, who spent more than 12 years in the role. Karloff is set to remain in an operational role and keep her place as chair of the board of directors at Invo.
Mass. hospital president moves to Boston Scientific
Newton-Wellesley Hospital president & CEO Dr. Michael Jaff is set to step down and take an executive role at Boston Scientific (NYSE:BSX), according to a report in the Boston Business Journal. Jaff had held the role since 2016. The hospital said Partners HealthCare chief clinical officer will replace Jaff on an interim basis until a permanent replacement is found.